Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease
Neeraj Narula, Emily C L Wong, Parambir S. Dulai, Neil Sengupta, John K. Marshall, Jean‐Frédéric Colombel, Walter Reinisch
Topics & Concepts
MedicineUstekinumabInfliximabInternal medicinePost-hoc analysisCalprotectinCrohn's diseaseOdds ratioRandomized controlled trialGastroenterologyInflammatory bowel diseaseDiseaseInflammatory Bowel DiseaseAutoimmune and Inflammatory DisordersBiosimilars and Bioanalytical Methods